Cargando…

Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients

BACKGROUND: High-dose methotrexate (HD-MTX) with folinic acid (leucovorin) rescue is “gold standard” therapy for osteosarcoma. Plasma concentrations of methotrexate (MTX) are closely related to its efficacy and toxicity. Delayed excretion of MTX can lead to serious adverse reactions that may result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Zhang, Qing, Zheng, Ting-Ting, Zhen, Jian-Cun, Niu, Xiao-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125329/ https://www.ncbi.nlm.nih.gov/pubmed/27779157 http://dx.doi.org/10.4103/0366-6999.192781

Ejemplares similares

Two Pediatric Osteosarcoma Cases with Delayed Methotrexate Excretion: Its Clinical Course and Management
por: Lee, Kang Min, et al.
Publicado: (2011)

Population Pharmacokinetics of High-dose Methotrexate After Intravenous Administration in Chinese Osteosarcoma Patients from a Single Institution
por: Zhang, Wei, et al.
Publicado: (2015)

Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate
por: Yang, Shi-Long, et al.
Publicado: (2015)

Nomogram predicting leukopenia in osteosarcoma after high-dose methotrexate chemotherapy
por: Wu, Haixiao, et al.
Publicado: (2022)

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
por: Hegyi, Marta, et al.
Publicado: (2016)

Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma
por: Park, Jeong A, et al.
Publicado: (2016)

Safety and efficacy of high‐dose methotrexate for osteosarcoma in adolescents compared with young adults
por: Wippel, Brittany, et al.
Publicado: (2018)

Voriconazole injection may induce delayed methotrexate excretion: a case report and experimental study
por: Watahiki, Daisuke, et al.
Publicado: (2022)

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017)

Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients
por: Mosleh, Ema, et al.
Publicado: (2023)

MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients
por: Xu, Leilei, et al.
Publicado: (2018)

Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma--experience in Korea cancer hospital.
por: Lee, S. Y., et al.
Publicado: (1993)

Effect of co‐medications and potential risk factors of high‐dose methotrexate‐mediated acute hepatotoxicity in patients with osteosarcoma
por: Wang, Sheng‐Fan, et al.
Publicado: (2023)

Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines
por: Yang, Xiao-rong, et al.
Publicado: (2015)

Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance
por: Ramsey, Laura B., et al.
Publicado: (2017)

Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
por: Michelagnoli, M P, et al.
Publicado: (1999)

Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
por: Rossi, Barbara, et al.
Publicado: (2010)

Stroke-like encephalopathy following high-dose intravenous methotrexate in an adolescent with osteosarcoma: a case report
por: Valle, Daniel Almeida do, et al.
Publicado: (2016)

More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate
por: Xie, Lu, et al.
Publicado: (2017)

High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance
por: Chen, Aaron R, et al.
Publicado: (2020)

Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma
por: Cheng, Chieh‐Lung, et al.
Publicado: (2023)

Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies
por: Taylor, Zachary L., et al.
Publicado: (2021)

The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
por: Zhang, Bin, et al.
Publicado: (2020)

Patient-derived osteosarcoma cells are resistant to methotrexate
por: dos Santos Cavalcanti, Amanda, et al.
Publicado: (2017)

The Role of Single Nucleotide Polymorphisms in Transporter Proteins and the Folate Metabolism Pathway in Delayed Methotrexate Excretion: A Case Report and Literature Review
por: Wang, Jun, et al.
Publicado: (2022)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
por: Gao, Xuan, et al.
Publicado: (2021)

Methotrexate enterotoxicity: influence of drug dose and timing in the rat.
por: Pinkerton, C. R., et al.
Publicado: (1984)

Impairment of Methotrexate Transport Is Common in Osteosarcoma Tumor Samples
por: Sowers, Rebecca, et al.
Publicado: (2011)

Co-Delivery of Methotrexate and Nanohydroxyapatite with Polyethylene Glycol Polymers for Chemotherapy of Osteosarcoma
por: Ou, Lingbin, et al.
Publicado: (2023)

Is folate absorption impaired by high dose methotrexate?
por: Pinkerton, C. R.
Publicado: (1983)

Preventing and Managing Toxicities of High-Dose Methotrexate
por: Howard, Scott C., et al.
Publicado: (2016)

MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment
por: Zhang, Wenchao, et al.
Publicado: (2021)

The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Evidence-Based Criteria Supporting Early Discharge for Pediatric Patients With Osteosarcoma Receiving High-Dose Methotrexate: A Retrospective Chart Review
por: Armideo, Erin, et al.
Publicado: (2022)

Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high-dose methotrexate based on individual pharmacokinetics: A retrospective study
por: Nagamine, Ayumu, et al.
Publicado: (2022)

Predicting Hepatotoxicity Associated with Low-Dose Methotrexate Using Machine Learning
por: Hu, Qiaozhi, et al.
Publicado: (2023)

On the Influence of Baths on the Excretions
Publicado: (1859)

Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2019)

Genomic DNA Hypomethylation Is Associated with Neural Tube Defects Induced by Methotrexate Inhibition of Folate Metabolism
por: Wang, Xiuwei, et al.
Publicado: (2015)

Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia
por: Zhan, Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gfrpifc59qkubm9vqlao0lrqpj